Amarin Corporation plc (ADR) (AMRN) Releases Earnings Results, Misses Expectations By $-0.03 EPS

Amarin Corporation plc (ADR) (AMRN) reported quarterly earnings results on Thursday, May-5-2016. The company reported $-0.14 earnings per share for the quarter, missing the analyst consensus estimate by $-0.03. Analysts had a consensus of $-0.11. The company posted revenue of $25.50 million in the period, compared to analysts expectations of $27.81 million. The company’s revenue was up 60.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.16 EPS.

Amarin Corporation plc (ADR) closed down -0.1 points or -5.26% at $1.8 with 10,44,269 shares getting traded on Wednesday. Post opening the session at $1.88, the shares hit an intraday low of $1.8 and an intraday high of $1.918 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

In a different news, on Feb 3, 2016, John F Thero (CEO) purchased 25,000 shares at $1.37 per share price.

Amarin Corporation plc (Amarin) is a biopharmaceutical company. The Company is engaged in the commercialization and development of therapeutics for cardiovascular health. Amarin’s lead product Vascepa (icosapent ethyl) capsules are used as an adjunct to diet to reduce triglyceride levels in adult patients with severe (triglyceride or TG over 500 milligrams per deciliter) hypertriglyceridemia. The Company sells Vascepa principally to various wholesalers as well as regional wholesalers and specialty pharmacy providers who in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers. Vascepa is available in the United States by prescription only. Amarin is also developing Vascepa for the treatment of patients with high (TG over 200 milligrams per deciliter and less than 500 milligrams per deciliter) triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol (LDL-C) levels.

Amarin Corporation plc (ADR)

Leave a Reply

Amarin Corporation plc (ADR) - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amarin Corporation plc (ADR). Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.